InvestorsHub Logo
Followers 30
Posts 4372
Boards Moderated 0
Alias Born 03/20/2011

Re: FACT-MASTER post# 126

Friday, 05/12/2023 8:38:34 PM

Friday, May 12, 2023 8:38:34 PM

Post# of 265
TCRX: Novartis collaboration news (old news)

https://www.sec.gov/Archives/edgar/data/1783328/000095012321003678/filename3.htm

https://www.biospace.com/article/tscan-and-novartis-partner-to-develop-immune-therapies-for-solid-tumors/

https://www.biopharminternational.com/view/tscan-therapeutics-novartis-collaborate-t-cell-receptor-therapies

Collaboration period ended March 31/23 = 180 day countdown for Novartis to exercise licensing (Sept.28/23 deadline to advise on intent to license/Tscan notice of intent to license to third party)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News